Antonio Nuccio

机构：Vita-Salute San Raffaele University, Université Paris-Saclay, Institut Gustave Roussy, IRCCS Ospedale San Raffaele · ORCID：0009-0005-3571-7006

发表论文 41 篇 · 总被引 257 次 · h-index 6

代表论文

• Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC (2024 · Journal of Thoracic Oncology · 被引 86)
• Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis (2024 · Journal of Thoracic Oncology · 被引 46)
• Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies (2023 · European Journal of Cancer · 被引 40)
• Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle? (2023 · Cancer Treatment Reviews · 被引 13)
• Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis (2025 · JNCI Journal of the National Cancer Institute · 被引 12)
• Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis (2026 · European Journal of Surgical Oncology · 被引 6)